Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up
← Back to home

National Cancer Institute, Naples

Clinical trials sponsored by National Cancer Institute, Naples, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

  • New hope for Hard-to-Treat colorectal cancer: targeted drug shows promise Results expected Oct 2026 (estimated)
  • Can a mood stabilizer help fight colorectal cancer? Results expected Dec 2026 (estimated)
  • New drug shows promise for rectal cancer patients Results expected Jan 2027 (estimated)
  • New PET tracer may reveal hidden cancer targets Results expected Jan 2027 (estimated)
  • AI takes the wheel in cancer surgery: a smarter way to manage fluids? Results expected Feb 2027 (estimated)
Browse trials soon ready across all sponsors →
Trials to join now! 12 Not yet recruiting 4 Not yet finished but already full! 1
Sort by
  • Experimental vaccine aims to stop liver cancer from returning

    Disease control Ongoing

    This early-phase trial tests a cancer vaccine (IMA970A) combined with an immunotherapy drug (durvalumab) in 10 patients with early- to intermediate-stage liver cancer who have already received standard treatments. The goal is to see if the combination is safe and can help reduce …

    Phase 1 • Sponsor: National Cancer Institute, Naples • Aim: Disease control

    Last updated Jun 27, 2026 08:06 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse Glossary About Terms of use Contact us

This is a site from Cyber and Space